MarketPeel
Insider Trading Intelligence
LB

Luca Benatti

QNCX
DIRECTOR · QUINCE THERAPEUTICS, INC. · CIK 0001613842
FILING MIX · LIFETIME80%/20%
BUYS
4
SELLS
1
TOTAL VALUE
$173.5K
COMPANIES
1
ACTIVE SINCE
Oct 2023
HOLDINGS NOW
39,179
AVG SELL PX
$3.47
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Luca Benatti, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-15.73%-1.03%-14.70%-14.70%
14d1+100.00%-24.44%+0.55%-24.98%-24.98%
30d1+100.00%-16.29%+0.35%-16.64%-16.64%
60d1+100.00%-96.10%-0.43%-95.67%-95.67%
90d1+100.00%-97.36%-6.55%-90.81%-90.81%
180d1+100.00%-97.28%+6.27%-103.55%-103.55%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
QNCX · 39,179 shares · as of Dec 26, 2025
022,29544,59066,88489,17920242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 4 buys / 1 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
QNCX
QUINCE THERAPEUTICS, INC.
SALE
50,000$3.47$173.5K39,179Dec 26, 2025Dec 29, 2025View →
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,00027,000Jun 4, 2025Jun 6, 2025View →
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASE
8,91889,179Oct 23, 2024Dec 29, 2025View →
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,00027,000Jun 5, 2024Jun 7, 2024View →
QNCX
QUINCE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
54,00054,000Oct 23, 2023Oct 24, 2023View →
Other insiders · QNCX
Loading peer insiders…
About this filer
CIK 0001613842
ROLE
Director
PRIMARY
QNCX
COMPANIES
1
ACTIVE SINCE
Oct 2023
MARKETPEEL · /INSIDER/0001613842DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback